MetaADEDB 2.0 @ LMMD
Rhabdomyoma
(UMLS:C0035411)
Definition:
A benign tumor derived from striated muscle. It is extremely rare, generally occurring in the tongue, neck muscles, larynx, uvula, nasal cavity, axilla, vulva, and heart. These tumors are treated by simple excision. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1354)
UMLS ID:
C0035411
MeSH ID:
D012207
Classification:
Name:
Neoplasms
MeSH Tree Number(s):
C04.557.450.590.540.700
Synonym(s)
1.
Rhabdomyoma
2.
RHABDOMYOMA, BENIGN
3.
Rhabdomyoma NOS
4.
Rhabdomyoma, NOS
5.
Rhabdomyoma, no ICD-O subtype
6.
Rhabdomyoma, no International Classification of Diseases for Oncology subtype
7.
Rhabdomyomatous Neoplasm
8.
Rhabdomyomatous neoplasm
9.
[M]Rhabdomyoma NOS
10.
rhabdomyoma
11.
rhabdomyomas
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1ParoxetineFAERS: 4US FAERS
217 alpha-Hydroxyprogesterone CaproateFAERS: 1US FAERS
3AlprostadilFAERS: 1US FAERS
4CarbamazepineFAERS: 1US FAERS
5CefuroximeFAERS: 1US FAERS
6DigoxinFAERS: 1US FAERS
7EverolimusFAERS: 1US FAERS
8GoserelinFAERS: 1OFFSIDES
US FAERS
9PravastatinFAERS: 1US FAERS
10RisperidoneFAERS: 1US FAERS
11ziprasidoneFAERS: 1US FAERS
Similar ADE(s)
NameSemantic Similarity
1Smooth Muscle Tumor36%
2leiomyosarcoma35.3%
3Alveolar Soft Part Sarcoma35.3%
4Sarcoma28.5%
5Rhabdomyosarcoma23.3%
6leukemia22.7%
7Neoplasms, Germ Cell and Embryonal22.7%
8Neoplasms, Glandular and Epithelial22.7%
9Germ Cell Cancer22.7%
10Chondrosarcoma22.5%
11liposarcoma22.5%
12synovial sarcoma22.5%
13Angiomyolipoma22.5%
14Clear Cell Sarcoma of Soft Tissue22.5%
15Carcinosarcoma19.5%
16Hemangiosarcoma19.5%
17lymphangiosarcoma19.5%
18Fibrosarcoma18.6%
19Osteosarcoma18.6%
20Alveolar rhabdomyosarcoma17.4%
21Phyllodes Tumor16.8%
22Lipoma16.8%
23Myxoma16.8%
24Angiolipoma16.8%
25Myelolipoma16.8%
26Neoplasms, Bone Tissue16.8%
27Neoplasms, Fibrous Tissue16.8%
28Desmoplastic Small Round Cell Tumor16.8%
29Chondroma16.8%
30Enchondroma16.8%
31Malignant Fibrous Histiocytoma16.7%
32Neuroectodermal Tumors16.4%
33Sarcoma, Myeloid16%
34Hamartoma15.3%
35Neoplasms, Hormone-Dependent15.3%
36Neoplasms, Multiple Primary15.3%
37Paraneoplastic Syndromes15.3%
38Precancerous Conditions15.3%
39Neoplasms, Second Primary15.3%
40Histiocytic Disorders, Malignant15.1%
41Giant Cell Tumor of Bone14.8%
42Neoplasms, Neuroepithelial13.4%
43Gliomatosis cerebri13.4%
44Carcinoma 256, Walker13.1%
45Dermatofibrosarcoma12.9%
46Dermatofibrosarcoma Protuberans12.9%
47Sarcoma, Experimental12.3%
48Adenoma12.2%
49Ameloblastoma12.2%
50Angiokeratoma12.2%
51Carcinoma12.2%
52Chordoma12.2%
53Hemangioma12.2%
54hemangiopericytoma12.2%
55Lymphangioma12.2%
56Mesenchymoma12.2%
57Nevus12.2%
58Teratoma12.2%
59Hepatoblastoma12.2%
60Mixed Tumor, Mullerian12.2%
61Germinoma12.2%
62Teratocarcinoma12.2%
63Angiofibroma12.2%
64Epithelioma12.2%
65Lymphoma11.3%
66fibroma11.1%
67Fibromatosis11.1%
68Osteoblastoma11.1%
69Osteoma11.1%
70Chondromatosis11.1%
71melanoma10.8%
72Meningioma10.4%
73Adenofibroma10.3%
74Fibroadenoma10.3%
75Sarcoma 18010.2%
76Cyst10.2%
77Neoplastic Processes10.2%
78Neoplastic Syndromes, Hereditary10.2%
79Pregnancy Complications, Neoplastic10.2%
80Trophoblastic Neoplasms10%
81Leukemia, Experimental10%
82Carcinoma, Ehrlich Tumor9.9%
83Dermoid Cyst9.9%
84Carcinoma, Lewis Lung9.9%
85Neoplasms, Experimental9.9%
86Composite Lymphoma9.8%
87Leukemia, Plasma Cell9.7%
88Lymphangioleiomyomatosis9.6%
89Basal cell carcinoma9.6%
90Carcinoma, Papillary9.6%
91Squamous cell carcinoma9.6%
92Craniopharyngioma9.6%
93Cystadenoma9.6%
94Mesothelioma9.6%
95Neuroectodermal Tumor, Melanotic9.6%
96Neuroendocrine Tumors9.6%
97Carcinoma, Basal Cell9.6%
98Endometrial Stromal Sarcoma9.3%
99Mastocytosis8.7%
100Gastrointestinal Stromal Tumors8.6%
101Adenoma, Acidophil8.4%
102Ganglioneuroma8.4%
103Glioma8.4%
104Malignant Glioma8.4%
105Fibromatosis, Aggressive8.3%
106Fibromatosis, Abdominal8.3%
107Plasmacytoma8.2%
108Malignant histiocytosis8.1%
109Histiocytic sarcoma8.1%
110Leukemia, Radiation-Induced8.1%
111Neurofibrosarcoma8%
112Cystadenocarcinoma8%
113Mucoepidermoid Carcinoma8%
114Leukemia L12107.6%
115Leukemia P3887.6%
116Acanthoma7.6%
117Abdominal Neoplasms7.6%
118Erythroplasia7.6%
119Follicular cyst7.6%
120Head and Neck Neoplasms7.6%
121Mucocele7.6%
122Pilonidal Cyst7.6%
123Soft Tissue Neoplasms7.6%
124Thoracic Neoplasms7.6%
125Thyroglossal Cyst7.6%
126Synovial Cyst7.6%
127Aberrant Crypt Foci7.6%
128Mastocytoma7.5%
129Mastocytosis, Systemic7.4%
130Neoplasms, Radiation-Induced7.4%
131Thymoma7.3%
132Melanoma, Experimental7.3%
133Adenocarcinoma7.2%
134Carcinoma in Situ7.2%
135Carcinoma, Transitional Cell7.2%
136Dysgerminoma7.2%
137Hemangioendothelioma7.2%
138Neuroma7.2%
139Papilloma7.2%
140Pseudomyxoma Peritonei7.2%
141Seminoma7.2%
142Papillomatosis7.2%
143Adenomatosis, Pulmonary7.2%
144Adenomatous Polyps7.2%
145Carcinoma, Large Cell7.2%
146Carcinoma, Small Cell7.2%
147Carcinoid Tumor7.1%
148Neurilemmoma7.1%
149Hutchinson's Melanotic Freckle7.1%
150Melanoma, Amelanotic7.1%
151Medulloblastoma6.8%
152Multiple Endocrine Neoplasia6.6%
153Choriocarcinoma6.5%
154Carcinoma, Lobular6.5%
155Bowen's Disease6.3%
156Paraganglioma6.3%
157Hodgkin Disease6.1%
158Lymphoma, Non-Hodgkin6.1%
159Paraneoplastic Encephalomyelitis6%
160Astrocytoma5.9%
161Ependymoma5.9%
162oligodendroglioma5.9%
163Ganglioglioma5.9%
164gliosarcoma5.9%
165Anaplastic astrocytoma5.9%
166Anaplastic Oligodendroglioma5.9%
167Mammary Neoplasms, Experimental5.8%
168Digestive System Neoplasms5.4%
169Endocrine Gland Neoplasms5.4%
170Eye Neoplasms5.4%
171Nervous System Neoplasms5.4%
172Malignant Carcinoid Syndrome5.3%
173Bone neoplasms5.1%
174Leukoplakia5.1%
175Lymphocele5.1%
176Pancreatic Cyst5.1%
177Skin Neoplasms5.1%
178Hematologic Neoplasms5.1%
179Barrett Esophagus5%
180Breast Cyst5%
181Actinic keratosis5%
182Mediastinal Cyst5%
183Neoplasm Invasiveness5%
184Neoplasm Metastasis5%
185Neoplasm Recurrence, Local5%
186Parovarian Cyst5%
187Pericardial Cyst5%
188Splenic Neoplasms5%
189Thymic Cyst5%
190Carcinogenesis5%
191Myxoid cyst5%
192Metastasis5%
193Primary amyloidosis4.9%
194Retinoblastoma4.9%
195Lymphomatoid Granulomatosis4.9%
196Leukemia, Myelomonocytic, Chronic4.8%
197Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative4.8%
198Adenoid Cystic Carcinoma4.8%
199Adenocarcinoma, Clear Cell4.8%
200Cholangiocarcinoma4.8%
201Cervical Intraepithelial Neoplasia4.8%
202Hemangioblastoma4.8%
203Lymphoma, Extranodal NK-T-Cell4.8%
204Pheochromocytoma4.7%
205Glioblastoma4.7%
206Neuroblastoma4.7%
207Glioblastoma Multiforme4.7%
208Nephroblastoma4.7%
209Tuberous Sclerosis4.6%
210Dupuytren Contracture4.3%
211Urticaria Pigmentosa4.2%
212Ganglioneuroblastoma4.1%
213Retroperitoneal Neoplasms4.1%
214Hepatocellular Adenoma3.9%
215Mesoblastic Nephroma3.9%
216Basal Cell Nevus Syndrome3.8%
217Sturge-Weber Syndrome3.7%
218Corpus Luteum Cyst3.7%
219Ovarian Cysts3.7%
220Hemangioma, Cavernous3.6%
221Carcinoid Heart Disease3.6%
222Leukemia, T-Cell3.6%
223Leukemia, B-Cell3.6%
224neurofibroma3.6%
225Hydatidiform Mole3.6%
226Lymphoma, Follicular3.6%
227T-Cell Lymphoma3.6%
228Mantle cell lymphoma3.6%
229Klatskin Tumor3.6%
230Multiple Endocrine Neoplasia Type 13.5%
231Waldenstrom Macroglobulinemia3.5%
232Multiple Myeloma3.5%
233Parathyroid Neoplasms3.4%
234Peritoneal Neoplasms3.4%
235Thyroid Neoplasm3.4%
236Thyroid carcinoma3.4%
237Carcinoma, Pancreatic Ductal3.3%
238Liver Neoplasms, Experimental3.3%
239Prolactinoma3.2%
240Growth Hormone-Secreting Pituitary Adenoma3.2%
241Leukemia, Myeloid, Chronic-Phase3.2%
242Choledochal Cyst3.1%
243Acoustic Neuroma3%
244Peutz-Jeghers Syndrome3%
245Pancreatic Neoplasm2.8%
246Mouth Neoplasms2.8%
247Central Nervous System Neoplasms2.8%
248Vascular Neoplasms2.8%
249Thymus Neoplasms2.8%
250granulosa cell tumor2.8%
251Carcinoma, Ovarian Epithelial2.8%
252Genital Neoplasms, Female2.7%
253Pancreatic Pseudocyst2.7%
254Lymphatic Metastasis2.7%
255Neoplasms, Unknown Primary2.7%
256Leukemic Infiltration2.7%
257Breast Neoplasms, Male2.7%
258Neoplasm Micrometastasis2.7%
259Triple Negative Breast Neoplasms2.7%
260Tracheal Neoplasms2.7%
261Optic Nerve Glioma2.7%
262Adenomatous Polyposis Coli2.7%
263Leukoplakia, Oral2.6%
264Paraneoplastic Cerebellar Degeneration2.6%
265Vipoma2.6%
266Precursor B-Cell Lymphoblastic Leukemia-Lymphoma2.4%
267Leukemia, Large Granular Lymphocytic2.4%
268Precursor T-Cell Lymphoblastic Leukemia-Lymphoma2.4%
269Lymphoma, T-Cell, Cutaneous2.4%
270Lymphoma, AIDS-Related2.4%
271Enteropathy-Associated T-Cell Lymphoma2.4%
272Primary Effusion Lymphoma2.4%
273insulinoma2.3%
274Esophageal Neoplasms2.2%
275Limbic Encephalitis2.2%
276Adrenocortical carcinoma2.1%
277Adrenal Gland Neoplasms2.1%
278Gastrointestinal Neoplasms2.1%
279Genital Neoplasms, Male2.1%
280Liver neoplasms2.1%
281Uveal Neoplasms2.1%
282Nasopharyngeal carcinoma2.1%
283Urologic Neoplasms2.1%
284Sebaceous Gland Neoplasms2.1%
285Spinal Neoplasms2.1%
286Bone Marrow Neoplasms2.1%
287Polycystic Ovary Syndrome2%
288Thyroid Nodule2%
289Gastrinoma1.9%
290Glucagonoma1.9%
291Denys-Drash Syndrome1.9%
292Lambert-Eaton Myasthenic Syndrome1.9%
293Testicular Neoplasms1.9%
294Leydig Cell Tumor1.9%
295Renal Cell Carcinoma1.8%
296Papillary Renal Cell Carcinoma1.8%
297Mycosis Fungoides1.8%
298Lymphomatoid Papulosis1.8%
299Plasmablastic lymphoma1.8%
300Carcinoma, Endometrioid1.7%
301Xeroderma Pigmentosum1.7%
302Opsoclonus-Myoclonus Syndrome1.7%
303Meningeal Neoplasms1.6%
304Burkitt Lymphoma1.6%
305Myelitis, Transverse1.5%
306ovarian neoplasm1.4%
307Nose Neoplasms1.3%
308Ear Neoplasms1.3%
309Eyelid Neoplasms1.3%
310Lung Neoplasms1.3%
311Pleural Neoplasms1.3%
312Cell Transformation, Viral1.2%
313Brain Neoplasms1.2%
314Salivary Gland Neoplasms1.2%
315Spinal Cord Neoplasms1.2%
316Tongue Neoplasms1.2%
317Uterine Neoplasms1.2%
318Vaginal Neoplasms1.2%
319Vulvar Neoplasms1.2%
320Uterine Cancer1.2%
321Sezary Syndrome1.2%
322Fallopian Tube Neoplasms1.2%
323Palatal Neoplasms1.2%
324Pituitary Adenoma1.1%
325Pituitary Neoplasms1.1%
326Meningeal Carcinomatosis1.1%
327Zollinger-Ellison syndrome1%
328Pharyngeal Neoplasms1%
329Central Nervous System Cysts1%
330Bile Duct Neoplasms1%
331gallbladder neoplasm1%
332Intestinal Neoplasms1%
333Penile Neoplasms1%
334Prostatic Neoplasms1%
335Stomach Neoplasms1%
336Polycythemia Vera1%
337Laryngeal neoplasm0.9%
338Bronchial Neoplasms0.8%
339Bladder Neoplasm0.8%
340Kidney Neoplasm0.8%
341Ureteral Neoplasms0.8%
342Urethral Neoplasms0.8%
343Multiple Pulmonary Nodules0.8%
344Supratentorial Neoplasms0.8%
345Endometrial Neoplasms0.8%
346Hypopharyngeal Neoplasms0.7%
347Pleural Effusion, Malignant0.7%
348Hypopharyngeal Cancer0.7%
349Parotid Neoplasms0.6%
350Prostatic Neoplasms, Castration-Resistant0.6%
351Nelson Syndrome0.6%
352Brain Stem Neoplasms0.6%
353Cecal Neoplasms0.5%
354Duodenal Neoplasms0.5%
355Choroid Plexus Papilloma0.5%
356Tonsillar Neoplasms0.5%
357Cerebellar Neoplasms0.5%
358Nasopharyngeal Neoplasms0.5%
359Colorectal Neoplasms0.5%
360Paranasal Sinus Neoplasms0.4%
361Radicular Cyst0.4%
362Appendiceal Neoplasms0.4%
363Colonic Neoplasms0.4%
364Rectal Neoplasms0.4%
365Maxillary Sinus Neoplasms0.3%
366Anus Neoplasms0.3%
367Sigmoid Neoplasms0.3%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.